Towards multi-drug adaptive therapy J West, L You, J Zhang, RA Gatenby, JS Brown, PK Newton, ... Cancer Research, 2020 | 174 | 2020 |
Turnover modulates the need for a cost of resistance in adaptive therapy MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ... Cancer Research 81 (4), 1135-1147, 2021 | 100 | 2021 |
Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy JB West, MN Dinh, JS Brown, J Zhang, AR Anderson, RA Gatenby Clinical Cancer Research 25 (14), 4413-4421, 2019 | 94 | 2019 |
The harsh microenvironment in early breast cancer selects for a Warburg phenotype M Damaghi, J West, M Robertson-Tessi, L Xu, MC Ferrall-Fairbanks, ... Proceedings of the National Academy of Sciences 118 (3), e2011342118, 2021 | 91 | 2021 |
Hybrid Automata Library: A flexible platform for hybrid modeling with real-time visualization RR Bravo, E Baratchart, J West, RO Schenck, AK Miller, J Gallaher, ... PLoS Computational Biology 16 (3), e1007635, 2020 | 81* | 2020 |
Normal tissue architecture determines the evolutionary course of cancer J West, RO Schenck, C Gatenbee, M Robertson-Tessi, ARA Anderson Nature Communications 12 (1), 1-9, 2021 | 72* | 2021 |
Capitalizing on competition: An evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment J West, Y Ma, PK Newton Journal of Theoretical Biology 455, 249-260, 2018 | 67* | 2018 |
Cellular interactions constrain tumor growth J West, PK Newton Proceedings of the National Academy of Sciences 116 (6), 1918-1923, 2019 | 63 | 2019 |
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition MAR Strobl, J Gallaher, J West, M Robertson-Tessi, PK Maini, ... Communications medicine 2 (1), 46, 2022 | 54 | 2022 |
An evolutionary model of tumor cell kinetics and the emergence of molecular heterogeneity driving Gompertzian growth J West, Z Hasnain, P Macklin, PK Newton SIAM Review 58 (4), 716-736, 2016 | 54 | 2016 |
Chemotherapeutic dose scheduling based on tumor growth rates provides a case for low-dose metronomic high-entropy therapies J West, PK Newton Cancer Research 77 (23), 6717-6728, 2017 | 45 | 2017 |
The prisoner’s dilemma as a cancer model J West, Z Hasnain, J Mason, PK Newton Convergent Science Physical Oncology 2 (3), 035002, 2016 | 45 | 2016 |
Immunosuppressive niche engineering at the onset of human colorectal cancer CD Gatenbee, AM Baker, RO Schenck, M Strobl, J West, MP Neves, ... Nature Communications 13 (1), 1798, 2022 | 33* | 2022 |
The immune checkpoint kick start: Optimization of neoadjuvant combination therapy using game theory J West, M Robertson-Tessi, K Luddy, DS Park, DFK Williamson, ... JCO Clinical Cancer Informatics 3, 1-12, 2019 | 31 | 2019 |
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, J Brown, ... Elife 12, e84263, 2023 | 29 | 2023 |
Agent-based methods facilitate integrative science in cancer J West, M Robertson-Tessi, ARA Anderson Trends in Cell Biology 33 (4), 300-311, 2023 | 26 | 2023 |
Working with convex responses: Antifragility from finance to oncology NN Taleb, J West Entropy 25 (2), 343, 2023 | 13 | 2023 |
A fuzzy logic approach to collision avoidance in smart UAVs M Hromatka, M Holt, J West, S Biaz | 11 | 2013 |
Treatment of evolving cancers will require dynamic decision support MAR Strobl, J Gallaher, M Robertson-Tessi, J West, ARA Anderson Annals of Oncology 34 (10), 867-884, 2023 | 9 | 2023 |
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics J Gallaher, M Strobl, J West, R Gatenby, J Zhang, M Robertson-Tessi, ... Cancer Research 83 (16), 2775-2789, 2023 | 9* | 2023 |